Skip to main content

Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001831363

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q1 2023

Institutional positions in Terns Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
79
+14 vs. Q4 2022
Shares held
53.2M
+3.49M (+7.0%) vs. Q4 2022
Total value
$630.2M
+$124.0M (+24.5%) vs. Q4 2022
New holders
27
26 more added
Sold out
13
15 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 79 institutions
Q1 2021: 42 institutionsQ2 2021: 36 institutionsQ3 2021: 34 institutionsQ4 2021: 37 institutionsQ1 2022: 44 institutionsQ2 2022: 42 institutionsQ3 2022: 45 institutionsQ4 2022: 65 institutionsQ1 2023: 79 institutionsQ2 2023: 103 institutionsQ3 2023: 93 institutionsQ4 2023: 103 institutionsQ1 2024: 112 institutionsQ2 2024: 126 institutionsQ3 2024: 156 institutionsQ4 2024: 157 institutionsQ1 2025: 138 institutionsQ2 2025: 130 institutionsQ3 2025: 141 institutionsQ4 2025: 248 institutionsQ1 2026: 317 institutionsQ2 2026: 1 institution
Value heldQ1 2023: $630.2M
Q1 2021: $393.7MQ2 2021: $203.8MQ3 2021: $174.3MQ4 2021: $116.7MQ1 2022: $50.0MQ2 2022: $36.5MQ3 2022: $178.1MQ4 2022: $506.2MQ1 2023: $630.2MQ2 2023: $505.0MQ3 2023: $310.4MQ4 2023: $412.7MQ1 2024: $414.8MQ2 2024: $446.7MQ3 2024: $663.1MQ4 2024: $477.2MQ1 2025: $229.4MQ2 2025: $310.0MQ3 2025: $665.7MQ4 2025: $4.95BQ1 2026: $6.56BQ2 2026: $75.4K
Institutions holding TERN and their total value by quarter
QuarterHoldersValue
Q2 20261$75.4K
Q1 2026317$6.56B
Q4 2025248$4.95B
Q3 2025141$665.7M
Q2 2025130$310.0M
Q1 2025138$229.4M
Q4 2024157$477.2M
Q3 2024156$663.1M
Q2 2024126$446.7M
Q1 2024112$414.8M
Q4 2023103$412.7M
Q3 202393$310.4M
Q2 2023103$505.0M
Q1 202379$630.2M
Q4 202265$506.2M
Q3 202245$178.1M
Q2 202242$36.5M
Q1 202244$50.0M
Q4 202137$116.7M
Q3 202134$174.3M
Q2 202136$203.8M
Q1 202142$393.7M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q4 2022.

Institutions holding TERN in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Aquatic Capital Management LLC100$1.00K0.00%+100New
Belpointe Asset Management LLC100$1.18K0.00%+100New
Signaturefd, LLC103$1.22K0.00%+103New
Lindbrook Capital, LLC130$1.54K0.00%+130New
Parallel Advisors, LLC161$1.91K0.00%+161New
Daiwa Securities Group Inc.151$2.00K0.00%00.0%Unchanged
Capital Advisors, Ltd. LLC188$2.00K0.00%00.0%Unchanged
TCI Wealth Advisors, Inc.200$2.37K0.00%+200New
Wells Fargo & Company209$2.48K0.00%+83+65.9%Added
China Universal Asset Management Co., Ltd.671$7.95K0.00%+288+75.2%Added
Zurcher Kantonalbank (Zurich Cantonalbank)2,482$29.4K0.00%−2,568−50.9%Reduced
Tower Research Capital LLC (TRC)3,650$43.0K0.00%−1,889−34.1%Reduced
Dark Forest Capital Management LP3,852$45.6K0.01%+3,852New
Point72 Middle East FZE5,084$60.2K0.00%+5,084New
UBS Group AG5,672$67.2K0.00%+5,672New
Connor, Clark & Lunn Investment Management Ltd.11,963$141.6K0.00%+11,963New
Crosspoint Financial, LLC12,054$142.7K1.54%−3,000−19.9%Reduced
Squarepoint Ops LLC12,925$153.0K0.00%+12,925New
Charles Schwab Investment Management Inc13,711$162.3K0.00%+13,711New
Man Group plc–$164.2K0.00%––
LMR Partners LLP15,849$187.7K0.00%+15,849New
683 Capital Management, LLC16,000$189.4K0.02%−12,000−42.9%Reduced
Fred Alger Management, LLC16,276$192.7K0.00%+16,276New
Jump Financial, LLC18,356$217.3K0.01%+18,356New
Cubist Systematic Strategies, LLC20,356$241.0K0.00%+15,491+318.4%Added
Bank of New York Mellon Corp20,388$241.4K0.00%+20,388New
Verition Fund Management LLC25,590$303.0K0.00%+25,590New
Alps Advisors Inc31,603$374.2K0.00%+6,078+23.8%Added
Mirabella Financial Services LLP33,334$394.7K0.08%+33,334New
Citigroup Inc45,393$537.5K0.00%−655−1.4%Reduced
D. E. Shaw & Co., Inc.46,762$553.7K0.00%+46,762New
Bank of America Corp47,951$567.7K0.00%+46,136+2,541.9%Added
Royal Bank of Canada50,004$592.0K0.00%+49,822+27,374.7%Added
Bridgeway Capital Management, LLC50,700$600.3K0.02%−42,000−45.3%Reduced
Qube Research & Technologies Ltd50,951$603.3K0.00%+40,406+383.2%Added
Atom Investors LP51,951$615.1K0.33%+51,951New
Northern Trust Corp55,079$652.1K0.00%+23,486+74.3%Added
Parkman Healthcare Partners LLC75,000$888.0K0.19%+75,000New
Goldman Sachs Group Inc89,304$1.06M0.00%+78,474+724.6%Added
Polar Asset Management Partners Inc.100,000$1.18M0.02%00.0%Unchanged
Integral Health Asset Management, LLC100,000$1.18M0.25%+100,000New
Renaissance Technologies LLC105,200$1.25M0.00%−9,700−8.4%Reduced
Schonfeld Strategic Advisors LLC115,252$1.36M0.01%+115,252New
State Street Corp119,039$1.41M0.00%+59,502+99.9%Added
Velan Capital Investment Management LP120,000$1.42M1.26%+109,354+1,027.2%Added
Boothbay Fund Management, LLC127,552$1.51M0.04%+1,670+1.3%Added
EAM Investors, LLC128,186$1.52M0.30%00.0%Unchanged
Morgan Stanley141,936$1.68M0.00%+123,878+686.0%Added
HighVista Strategies LLC146,854$1.74M1.42%+69,510+89.9%Added
Jane Street Group, LLC149,361$1.77M0.00%+127,854+594.5%Added
Marshall Wace, LLP185,028$2.19M0.01%+148,947+412.8%Added
Samsara BioCapital, LLC202,348$2.40M0.50%00.0%Unchanged
Dimensional Fund Advisors LP237,111$2.81M0.00%+138,171+139.7%Added
Geode Capital Management, LLC304,716$3.61M0.00%+127,068+71.5%Added
Susquehanna International Group, LLP328,028$3.88M0.01%+289,926+760.9%Added
Balyasny Asset Management LLC367,671$4.35M0.01%+367,671New
Citadel Advisors LLC392,065$4.64M0.01%−123,732−24.0%Reduced
Barclays PLC534,760$6.33M0.01%+18,021+3.5%Added
Invesco Ltd.574,177$6.80M0.00%+574,177New
Point72 Asset Management, L.P.629,098$7.45M0.03%+395,598+169.4%Added
JPMorgan Chase & Co631,746$7.48M0.00%−575,405−47.7%Reduced
Silverarc Capital Management, LLC667,922$7.91M3.55%−32,078−4.6%Reduced
BlackRock Inc.700,667$8.30M0.00%+401,229+134.0%Added
Decheng Capital Management III (Cayman), LLC714,285$8.46M3.41%00.0%Unchanged
Ikarian Capital, LLC721,341$8.54M3.55%−15,978−2.2%Reduced
Millennium Management LLC1,082,383$12.8M0.01%−374,822−25.7%Reduced
Acuta Capital Partners, LLC1,099,309$13.0M10.13%−691−0.1%Reduced
Vanguard Group Inc1,291,249$15.3M0.00%+165,213+14.7%Added
Perceptive Advisors LLC1,350,000$16.0M0.47%+1,350,000New
Franklin Resources Inc1,457,454$17.3M0.01%+707,430+94.3%Added
Braidwell LP1,997,055$23.6M0.78%+1,997,055New
Fairmount Funds Management LLC2,040,000$24.2M4.15%00.0%Unchanged
Deerfield Management Company, L.P. (Series C)2,059,421$24.4M0.54%−791,866−27.8%Reduced
Driehaus Capital Management LLC2,469,512$29.2M0.41%+175,136+7.6%Added
Suvretta Capital Management, LLC3,448,275$40.8M1.97%00.0%Unchanged
VR Adviser, LLC3,619,522$42.9M8.37%−88,369−2.4%Reduced
Vivo Capital, LLC6,657,992$78.8M5.90%00.0%Unchanged
OrbiMed Advisors LLC7,619,135$90.2M1.79%00.0%Unchanged
FMR LLC7,642,758$90.5M0.01%+264,117+3.6%Added
RTW Investments, LP0$00.00%−1,000,000−100.0%Sold out
Pura Vida Investments, LLC0$00.00%−605,079−100.0%Sold out
Armistice Capital, LLC0$00.00%−560,000−100.0%Sold out
Bank of Montreal0$00.00%−194,100−100.0%Sold out
Endurant Capital Management LP0$00.00%−135,994−100.0%Sold out
Monashee Investment Management LLC0$00.00%−122,500−100.0%Sold out
Walleye Capital LLC0$00.00%−73,611−100.0%Sold out
Altium Capital Management LP0$00.00%−70,000−100.0%Sold out
HRT Financial LP0$00.00%−35,090−100.0%Sold out
Acadian Asset Management LLC0$00.00%−22,599−100.0%Sold out
Caas Capital Management LP0$00.00%−20,000−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−15,709−100.0%Sold out
Raymond James & Associates0$00.00%−12,488−100.0%Sold out